Loading clinical trials...
Loading clinical trials...
Post-fall Syndrome of the Aged Person : Contribution of SAFEWALKER for Rehabilitation
The main objective of this study is to evaluate the feasibility and acceptability of the use of the robot "SAFEWALKER" complement classical rehabilitation in a group of elderly patients over 70 years during the rehabilitation of post-fall syndrome.
The post-fall syndrome is an acute functional complications of falls that affects nearly one in five elderly fallers. It combines phobia of the previous vacuum, axial and hypertension astasia abasia. Unrecognized and untreated, it progresses to a major regressive syndrome, severe physical, psychological and social implications. Only an early rehabilitation for an early resumption of walking, prevents such a development. The main element is to support and encourage the subject to walking. In practice, it was found that the physiotherapist can not be present daily and the duration of its intervention is often short-lived. This study will examine the contribution of a medical device of a walking aid (SAFEWALKER the robot) in the rehabilitation and empowerment of seniors with a post-fall syndrome. The SAFEWALKER, which is a walking aid device (http://www.safewalker.com), completes the support action exercised by a third person, by reducing support and securing travel. It allows the subject to move alone at will and is a continuity in relation to the management of the physiotherapist, a potential source of motivation. The hypothesis is that the SAFEWALKER device can be complementary to the walking rehabilitation in post-fall syndrome.
Age
70 - No limit years
Sex
ALL
Healthy Volunteers
No
Nourhashemi Fatemeh
Toulouse, MIDI Pyrenees, France
Start Date
June 10, 2015
Primary Completion Date
February 1, 2017
Completion Date
February 1, 2017
Last Updated
December 10, 2025
20
ACTUAL participants
SAFEWALKER
DEVICE
Lead Sponsor
University Hospital, Toulouse
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions